Survival of T- and B-Phenotype Diffuse Aggressive Non-Hodgkin's Lymphomas

References

• The non-Hodgkin's Lymphoma Pathological Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas; summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Fornace A. J., Jaffe E. S. 'Pathology of Malignant Lymphoma'. Neoplastic Diseases of the Blood II, P. H. Wiernik, G. P. Canellos, R. A. Kyle, S. A. Schiffer. Churchill Livingstone, New York 1985; 707–736
   Google Scholar
• Jaffe E. S., Strauchen J. A., Berard C. W. Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin's lymphomas. Am. J. Pathol 1982; 77: 46–49
   Web of Science ®Google Scholar
• Rudders R. A., DeLellis R. A., Ahl E. T., Bernstein S., Begg C. B. Adult non-Hodgkin's lymphoma. Correlation of cell surface marker phenotype with prognosis, the new Working Formulation, and the Rappaport and Lukes-Collin's Histomorphologic schemes. Cancer 1983; 52: 2289–2299
   PubMed Web of Science ®Google Scholar
• The T- and B-cell malignancy study group. Statistical analysis of immunologic, clinical and histopathologic data on lymphoid malignancies in Japan. Jpn. J. Clin. Oncol 1981; 11: 15–38
   Web of Science ®Google Scholar
• Cossman J., Jaffe E. S., Fisher R. I. Immunologic phenotypes of diffuse, aggressive non-Hodgkin's lymphomas. Correlation with clinical features. Cancer 1984; 54: 1310–1317
   PubMed Web of Science ®Google Scholar
• Levine A. M., Taylor C. R., Schneider D. R., Koehler S. C., Forman S. T., Lichtenstein A., Lukes R. J., Feinstein D. I. Immunoblastic sarcoma of T-cell v/s B-cell origin: I. Clinical features. Blood 1981; 58: 52–61
   PubMed Web of Science ®Google Scholar
• Horning S. J., Dogget R. S., Warnke R. A., Dorfman R. F., Cox R. S., Levy R. Clinical relevance of immunological phenotype in diffuse large cell lymphomas. Blood 1984; 63: 1209–1215
   PubMed Web of Science ®Google Scholar
• Coiffier B., Berger F., Bryon P-A., Magaud J-P. T-cell lymphomas: Immunologic, histologic, clinical and therapeutic analysis of 63 cases. J. Clin. Oncol 1989; 6: 1584–1589
   Web of Science ®Google Scholar
• Lymphoma Study Group. 1982 Final results of cooperative study of VEPA [vincristine, cyclophosphamide-(Endoxan), predinisolone and Adriamycin] therapy in advanced adult non-Hodgkin lymphomas. Relation between T- or B-cell phenotype and response. Jpn. J. Clin. Oncol 1978–1980; 12: 227–238
   Google Scholar
• Shimoyama M., Ota K., Kikuchi M., Yunoki K., Konda S., Takatsuki K., Ichimaru M., Ogawa M., Kimura I., Tominaga S., Tsugane S., Taguchi H, Minato K., Takenaka T., Tobinai K., Kurita S., Oyama A., Hisano S., Kozuru M., Matsumoto M., Nomura K., Takiguchi T., Sugai S., Yamaguchi K., Hattori T., Kinoshita K., Tajima K., Suemasu K. (Lymphoma Study Group 1988 Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M. J. Clin. Oncol 1981–1983; 6: 128–141
   Google Scholar
• Shimoyama M., Ota K., Kikuchi M., Yunoki K., Konda S., Takatsuki K., Ogawa M., Tominaga S., Tsugane S., Minato K., Takenaka T., Kurita S., Oyama A., Hisano S., Takiguchi T., Yamaguchi K., Tajima K., Suemasu K. (Lymphoma Study Group 1988 Major prognostic factors of adult patients with advanced B-cell lymphoma treated with VEPA or VEPA-M. Jpn. J. Clin. Oncol 1981–1983; 18: 113–124
   Google Scholar
• Shimizu K., Hamajima N., Ohnishi K., Hara K., Kunii A. T-cell phenotype is associated with decreased survival in non-Hodgkin's lymphoma. Jpn. J. Cancer Res 1989; 80: 720–726
   PubMedGoogle Scholar
• Shimoyama M., Ota K., Kikuchi M., Yunoki K., Konda S., Takatsuki K., Ichimaru M., Tominaga S., Tsugane S., Minato K., Tobinai K., Oyama A., Hisano S., Matsumoto M., Takiguchi T., Yamaguchi K., Kinoshita K., Tajima K., Suemasu K. Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. J. Clin. Oncol 1988; 6: 1088–1097
   PubMed Web of Science ®Google Scholar
• Weiss L. M., Bindl J. M., Picozzi V. J., Link M. P., Warnke R. A. Lymphoblastic lymphoma (LBL). An immunophenotype study of 26 cases with comparison to T-cell acute lymphoblastic leukemia (ALL). Blood 1986; 67: 474–478
   PubMed Web of Science ®Google Scholar
• Bernstein J. I., Coleman C. N., Strickler J. G., Dorfman R. F., Rosenberg S. A. Combined modality therapy for adults with small non-cleaved lymphoma (Burkitt and non-Burkitt type). J. Clin. Oncol 1986; 4: 474–478
   Google Scholar
• Watanabe S., Sato Y., Shimoyama M., Minato K., Shimosato Y. Immunoblastic lymphadenopathy, angioimmunoblastic lymphadenopathy and immunoblastic lymphadenopathy-like T-cell lymphoma. A spectrum of T-cell neoplasia. Cancer 1986; 58: 2224–2232
   PubMed Web of Science ®Google Scholar
• Suchi T., Lennert K., Tu L-Y., Kikuchi M., Sato E., Stanfield A. G. Histopathology and immunohisto-chemistry of peripheral T-cell lymphomas: A proposal for their classification. J. Clin. Pathol 1987; 40: 995–1015
   PubMed Web of Science ®Google Scholar
• Imamura N., Inada T., Mtasiwa D., Kuramoto A. Phenotype and function of Japanese adult T-cell leukaemia cells. Lancet 1989; II: 214
   Google Scholar
• Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T-cell leukemia: Clinical features and hematological features of 16 cases. Blood 1977; 50: 481–492
   PubMed Web of Science ®Google Scholar
• Imamura N., Kusunoki Y., Kajihara H., Okada K., Kuramoto A. Aggressive natural killer cell leukaemia/lymphoma with N901-positive surface phenotype: Evidence for the existence of a third lineage in lymphoid cells. Acta. Haematol 1988; 80: 121–128
   PubMed Web of Science ®Google Scholar
• Imamura N., Kuramoto A. Effect of splenectomy in aggressive large granular lymphocyte leukaemia. Br. J. Haematol 1988; 69: 577–578
   PubMed Web of Science ®Google Scholar
• Imamura N., Kuramato A. Analysis of peroxidase negative acute leukemias by monoclonal antibodies. III. Acute lymphoblastic leukemia. J. Clin. Lab. Analysis 1989; 3: 88–94
   PubMed Web of Science ®Google Scholar
• Imamura N., Saito O., Dohy H., Ogiu T. T-cell leukemia induced by 1-propyl-nitrosourea in Fischer rats. Experientia 1981; 37: 1339–1340
   PubMedGoogle Scholar
• Imamura N., Yanagihara K., Kusunoki Y. Tumor-associated antigen of spontaneous mammary tumor in rats. Oncology 1984; 41: 206–209
   PubMed Web of Science ®Google Scholar
• WHO Handbook for Reporting Results of Cancer Treatment. WHO offset publication No. 48. World Health Organisation, Geneva 1979
   Google Scholar
• Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubian W. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860–1861
   PubMed Web of Science ®Google Scholar
• Fisher R. I., Miller T. P., Dana B. W., Jones S. E., Dahlberg S., Coltman C. A. Southwest Oncology Group clinical trials for intermediate and high grade non-Hodgkin's lymphomas. Semin, Hematol 1987; 24: 21–25, (Suppl.1)
   PubMed Web of Science ®Google Scholar
• Fisher R. I., De Vita V. T., Hubbard S. M., Longo D. L., Wesley R., Chabner B. A., Young R. C. Diffuse aggressive lymphomas: Increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy. Ann. Intern. Med 1983; 98: 304–309
   PubMed Web of Science ®Google Scholar
• McKelvey E. M., Gottlieb J. A., Wilson H. E., Hault A., Talley R. W., Stephen R., Lane M., Gamble J. F., Jones S. E., Grozea P. N., Gutterman J., Coltman C., Moon T. E. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer 1976; 38: 1484–1493
   PubMed Web of Science ®Google Scholar
• Gomez G. A., Barcos M., Han T., Henderson E. Cyclophosphamide, Vincristine, Adriamycin, and Prednisolone, (CHOP), with or without intermediate dose MTX for treatment of non-Hodgkin's lymphoma of diffuse histology. Cancer 1987; 60: 18–24
   PubMed Web of Science ®Google Scholar
• Kaminski M. S., Coleman C. N., Colby T. V., Cox R. S., Rosenberg S. A. Factors predicting survival in adults with stage I and II large cell lymphoma treated with primary radiation therapy. Ann. Intern. Med 1986; 104: 747–756
   PubMed Web of Science ®Google Scholar
• Sullivan K. M., Neiman P. E., Kadin M. E., Dahlberg S., Farewell V. T., Rudolph R. H., Bagley C. M., Applebaum F. R., Thomas E. D. Combined modality therapy of advanced non-Hodgkin's lymphoma. An analysis of remission duration and survival in 95 patients. Blood 1973; 62: 51–61
   Google Scholar
• Cox D. R. Analysis of binary data. Chapman and Hall, London 1970
   Google Scholar
• Kaplan E. L., Meir P. Non-parametric estimation of incomplete observation. J. Ame. Stat. Ass 1958; 53: 457–481
   Web of Science ®Google Scholar
• Cox D. R., Oakes D. Analysis of surival data. Chapman and Hall, London 1984
   Google Scholar
• Cox D. R. Regression models and life tables. J. R. Stat. Soc. (Series B) 1972; 34: 187–200
   Web of Science ®Google Scholar